
|Articles|September 1, 2003
Bioplastique Unique
Author(s)Beth Kapes
Austin, Texas - The macroimplant Bioplastique (Uroplasty BV, Netherlands) biphasic copolymer is one tissue augmentation substance that has brought both benefits and complications to the European market, where it is currently available, Robert A. Ersek, M.D., said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5


















